The Peripheral T-Cell Lymphomas. Группа авторов

Angioimmunoblastic T‐cell Lymphoma and Other T Follicular Helper‐derived Malignancies Anaplastic Large‐cell Lymphomas Adult T‐cell Leukemia/Lymphoma Peripheral T‐cell Lymphoma Not Otherwise Specified Hepatosplenic T‐cell Lymphoma Extranodal natural killer/T‐cell Lymphoma Cutaneous T‐cell Lymphomas Conclusion Must Reads References

      8  Part III: Discrete Clinical Subtypes of PTCL (Unique Epidemiology, Therapy and Management) 8 Peripheral T‐cell Lymphoma Not Otherwise Specified Introduction Epidemiology, Risk Factors, and Clinical Characteristics Basic Principles of Disease Biology Prognostic Tools Frontline Therapy Management of Relapsed or Refractory Disease Future Directions Must Reads References 9 Angioimmunoblastic T‐cell Lymphoma Introduction Clinical and Biological Presentation Epidemiology and Risk Factors, Disease Incidence and Prevalence Basic Principles of Disease Biology Management of Disease in the Front Line Management of Relapsed or Refractory Disease Future Directions Must Reads References 10 The Spectrum of Anaplastic Large‐cell Lymphoma Introduction Epidemiology and Risk Factors Disease Incidence and Prevalence Basic Principles of Disease Biology Management of Disease in the Front Line Management of the Relapsed or Refractory Patient Future Directions Acknowledgement Must Reads References 11 Human T‐cell Lymphotropic Virus Type 1 Positive Adult T‐cell Leukemia/Lymphoma Epidemiology and Disease Incidence Basic Principles of Disease Biology CCR4 and Adult T‐cell Leukemia/Lymphoma Clinical Features of Adult T‐cell Leukemia/Lymphoma Prognosis and Prognostic Index of ATLL Front‐line Management of Aggressive Adult T‐cell Leukemia/Lymphoma Front‐line Management of Indolent ATLL Management of Relapsed or Refractory Patients Future Directions Must Reads References 12 Natural Killer/T‐cell Lymphomas Introduction Management of Newly Diagnosed Treatment‐naïve Patients Consolidation Treatment with Hematopoietic Stem‐cell Transplantation Management of Relapsed or Refractory Disease Future Directions Must Reads References 13 T‐Prolymphocytic Leukemia Introduction Must Reads References 14 Large Granular Lymphocyte Leukemia Introduction Epidemiology and Risk Factors Prevalence of Concomitant Disorders Basic Principles of Disease Biology Management of Disease in the Front Line Management of Relapsed or Refractory Disease Future Directions Funding Must